Loading…
Loading…
Molina Healthcare NYSE: MOH reaffirmed its full-year 2026 adjusted earnings outlook while outlining preliminary 2027 earnings building blocks exceeding $9.50 per share, supported by anticipated rate increases, the maturation of new contracts and the planned exit from its Medicare Advantage prescription drug business.
Molina Healthcare, Inc. ( MOH ) Q3 2026 Earnings Call October 22, 2026 8:00 AM EDT Company Participants Jeffrey Geyer - Head of Investor Relations Joseph Zubretsky - President, CEO & Director Mark Keim - Senior EVP, CFO & Treasurer Conference Call Participants Andrew Mok - Barclays Bank PLC, Research Division Kevin Fischbeck - BofA Securities, Research Division John Stansel - JPMorgan Chase & Co, Research Division Justin Lake - Wolfe Research, LLC Albert Rice - UBS Investment Bank, Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Sarah James - Cantor Fitzgerald & Co., Research Division David Windley - Jefferies LLC, Research Division Ryan Langston - TD Cowen, Research Division Lance Wilkes - Bernstein Institutional Services LLC, Research Division Michael Ha George Hill - Deutsche Bank AG, Research Division Presentation Operator Good day, and welcome to the Molina Healthcare Third Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Molina (MOH) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $1.84 per share a year ago.
While the top- and bottom-line numbers for Molina (MOH) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third quarter 2026 GAAP income per diluted share of $0.73 and adjusted income per diluted share of $0.89. Financial results are summarized below: Three months ended Nine months ended September 30, September 30, 2026 2025 2026 2025 (In millions, except per-share results) Premium Revenue $10,457 $10,841 $30,873 $32,337 Total Revenue $11,082 $11,477 $32,.
AUSTIN, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage : In today's healthcare landscape, treating sickness after the fact is giving way to stopping it before it starts. U.S. health spending hit $5.3 trillion in 2024, and Medicare Advantage enrolls 35.2 million people today, equal to 55% of those eligible.
Besides Wall Street's top-and-bottom-line estimates for Molina (MOH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.
Molina Healthcare, Inc. MOH is set to report its third-quarter 2026 results on Oct. 21, 2026, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at 72 cents per shareon revenues of $10.93 billion.